<unk> , sold under the brand name Exforge among others, is a blood pressure lowering combination drug. It contains<unk> , a dihydropyridine-type calcium channel blocker, and<unk> , an angiotensin receptor blocker. This combination is usually well tolerated and effective for the reduction of blood pressure. The combination was approved for medical use in the United States in June 2007. The combination is also available with included hydrochlorothiazide (Exforge HCT), for people who need a three-drug regimen to manage their blood pressure. It was approved for medical use in the United States in April 2009.
Amlodipine/valsartan
Enalapril/hydrochlorothiazide
Losartan/hydrochlorothiazide
Amlodipine/benazepril
Olmesartan/hydrochlorothiazide
Telmisartan/hydrochlorothiazide
Valsartan/hydrochlorothiazide
Lisinopril/hydrochlorothiazide